Literature DB >> 14606079

Establishment of a cell-based assay system for hepatitis C virus serine protease and its primary applications.

Hong-Xia Mao1, Shui-Yun Lan, Yun-Wen Hu, Li Xiang, Zheng-Hong Yuan.   

Abstract

AIM: To establish an efficient, sensitive, cell-based assay system for NS3 serine protease in an effort to study further the property of hepatitis C virus (HCV) and develop new antiviral agents.
METHODS: We constructed pCI-neo-NS3/4A-SEAP chimeric plasmid, in which the secreted alkaline phosphatase (SEAP) was fused in-frame to the downstream of NS4A/4B cleavage site. The protease activity of NS3 was reflected by the activity of SEAP in the culture media of transient or stable expression cells. Stably expressing cell lines were obtained by G418 selection. Pefabloc SC, a potent irreversible serine protease inhibitor, was used to treat the stably expressing cell lines to assess the system for screening NS3 inhibitors. To compare the activity of serine proteases from 1b and 1a, two chimeric clones were constructed and introduced into both transient and stable expression systems.
RESULTS: The SEAP activity in the culture media could be detected in both transient and stable expression systems, and was apparently decreased after Pefabloc SC treatment. In both transient and stable systems, NS3/4A-SEAP chimeric gene from HCV genotype 1b produced higher SEAP activity in the culture media than that from 1a.
CONCLUSION: The cell-based system is efficient and sensitive enough for detection and comparison of NS3 protease activity, and screening of anti-NS3 inhibitors. The functional difference between NS3/4A from 1a and 1b subtypes revealed by this system provides a clue for further investigations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14606079      PMCID: PMC4656523          DOI: 10.3748/wjg.v9.i11.2474

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

1.  A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone.

Authors:  G Saracco; A Ciancio; A Olivero; A Smedile; L Roffi; G Croce; C Colletta; G Cariti; M Andreoni; A Biglino; G Calleri; G Maggi; G F Tappero; P G Orsi; N Terreni; A Macor; A Di Napoli; E Rinaldi; G Ciccone; M Rizzetto
Journal:  Hepatology       Date:  2001-07       Impact factor: 17.425

2.  Substrate determinants for cleavage in cis and in trans by the hepatitis C virus NS3 proteinase.

Authors:  R Bartenschlager; L Ahlborn-Laake; K Yasargil; J Mous; H Jacobsen
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

3.  Conservation and variability in the structures of serine proteinases of the chymotrypsin family.

Authors:  A M Lesk; W D Fordham
Journal:  J Mol Biol       Date:  1996-05-10       Impact factor: 5.469

4.  Recombinant human insulin-like growth factor (IGF) binding protein-3 stimulates prostate carcinoma cell proliferation via an IGF-dependent mechanism. Role of serine proteases.

Authors:  P Angelloz-Nicoud; L Harel; M Binoux
Journal:  Growth Regul       Date:  1996-09

5.  Temperature dependent expression of cdc2 and cyclin B1 in spermatogenic cells during spermatogenesis.

Authors:  W H Kong; G Zheng; J N LU; J K Tso
Journal:  Cell Res       Date:  2000-12       Impact factor: 25.617

6.  Establishment of a simple assay in vitro for hepatitis C virus NS3 serine protease based on recombinant substrate and single-chain protease.

Authors:  Gui-Xin Du; Li-Hua Hou; Rong-Bin Guan; Yi-Gang Tong; Hai-Tao Wang
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

7.  Interferon alfa down-regulates CD81 in patients with chronic hepatitis C.

Authors:  B Kronenberger; B Rüster; R Elez; S Weber; A Piiper; J H Lee; W K Roth; S Zeuzem
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

8.  Suppression of actinomycin D-induced apoptosis by the NS3 protein of hepatitis C virus.

Authors:  T Fujita; S Ishido; S Muramatsu; M Itoh; H Hotta
Journal:  Biochem Biophys Res Commun       Date:  1996-12-24       Impact factor: 3.575

9.  Activity of purified hepatitis C virus protease NS3 on peptide substrates.

Authors:  C Steinkühler; A Urbani; L Tomei; G Biasiol; M Sardana; E Bianchi; A Pessi; R De Francesco
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

10.  Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells.

Authors:  D Sakamuro; T Furukawa; T Takegami
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  1 in total

1.  Development of a cell-based hepatitis C virus infection fluorescent resonance energy transfer assay for high-throughput antiviral compound screening.

Authors:  Xuemei Yu; Bruno Sainz; Susan L Uprichard
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.